Novavax’s Covid-19 vaccine shown to be 89% effective
Published
US biotech says its jab also displayed ‘significant clinical efficacy’ against two virus variants
Full ArticlePublished
US biotech says its jab also displayed ‘significant clinical efficacy’ against two virus variants
Full ArticleThe Janssen results come after the Novavax jab also appeared effective
A vaccine from Novavax, of which the UK has secured 60 million doses, has been shown to be 89% effective in preventing Covid-19